Portal de investigación
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Preserved Ejection Fraction.
Datos básicos
Documentos
- No hay documentos
Grupos
Financiadores - Promotores
CARDURION PHARMACEUTICALS INC.
Cita
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Preserved Ejection Fraction. (CRD-750-202). CARDURION PHARMACEUTICALS INC. 2024-2025. IP:LUIS ALMENAR BONET.